Wait to buy Hims & Hers Health (HIMS) at $31 until after earnings, targeting a 20% narrative-driven pullback to accumulate shares at a discount.

Capitalize on Nebius (NBIS) trading at $187 by treating short-seller pressure as a buying opportunity for this high-growth AI infrastructure play with a $51 billion pipeline.

Exercise patience with Nebius (NBIS) by avoiding pre-earnings bets and waiting for short-term volatility to secure better entry points.

Target CoreWeave (COREW), valued at an $82 billion market cap, as a top pure-play NeoCloud candidate if a broader market pullback creates a 30% discount.

Hims & Hers Health (HIMS)

• Trading at $31 per share with extreme 30-day volatility measured at 94%, which is higher than many cryptocurrencies.
• Long-term outlook is viewed as very positive, acting as an all-in-one healthcare platform for small-to-medium health problems that bypasses traditional insurance.
• Key catalysts to watch during upcoming earnings include:
  • Expansion and popularity of wearables and their scale launch for tracking GLP-1 weight loss.
  • Growth metrics and revenue share breakdown for GLP-1 offerings compared to traditional weight loss and metformin bills.
  • Timelines for peptide launches, anticipated around early 2027.
  • Integration updates and long-term outlook updates regarding the Eucalyptus acquisition.
  • Product mix performance across erectile dysfunction (ED) segments, testosterone, HERS growth, and anxiety treatments.
• Risk factors and market fears (FUD) mentioned:
  • Potential FTC lawsuits and associated legal fees or fines (viewed as a long-term non-issue).
  • Potential criticisms regarding marketing spend.
  • Temporary slowdowns or shifts in the ED product mix.
  • General market sell-offs despite strong earnings reports.

Takeaways

• Avoid opening new positions prior to earnings due to the current high-volatility "casino" market environment where excellent earnings have frequently been met with sell-offs.
• Wait for potential market overreactions or narrative-driven 20% drawdowns to consider accumulating shares at a discount.

Nebius (NBIS)

• Trading at $187 per share with an extremely high 30-day volatility of 130%.
• Recent price drops are attributed largely to loud short positions taken by investor Michael Burry rather than fundamental business weakness.
• Positioned favorably compared to other NeoClouds, featuring an elite management team composed of former Yandex executives.
• Highlighted business metrics and assets:
  • Boasts massive upcoming pipelines with reported revenue expectations of $51 billion over the next five years, making expected revenue higher than the current enterprise value.
  • Rumored upcoming major contracts, including a potential $33 billion deal in Missouri potentially involving Google.
  • Owns a 26% stake in ClickHouse, a high-value data company valued at $15 billion in January 2026 with potential to rival Snowflake.
  • Holds a stake in AVRide backed by an investment from Uber.
  • Anticipated revenue growth numbers are projected by the speaker to potentially reach between 500% and 1,000%+.

Takeaways

• Consider Nebius an attractive high-growth AI infrastructure play that is currently trading at a discount due to short-seller sentiment.
• Exercise patience by avoiding pre-earnings bets and instead target entry points following potential short-term market volatility or pullbacks.

CoreWeave (COREW)

• Trading with a market cap of $82 billion and a 30-day volatility of 100%, showing relative stability compared to Nebius.
• Identified as the original NeoCloud provider, holding a massive backlog worth $99 billion with a significant portion to be recognized over 24 months.
• Faces market skepticism driven by debt concerns and criticisms surrounding its OpenAI agreements.
• Shows strong pricing stability for tokens, with companies increasingly willing to pay more for compute power.
• Listed as the number one holding in a newly launched NeoCloud ETF, highlighting strong sector interest.

Takeaways

• CoreWeave serves as a strong pure-play NeoCloud candidate for investment additions if a broader market pullback creates a 30% discount.